InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: None

Wednesday, 09/04/2019 8:19:06 PM

Wednesday, September 04, 2019 8:19:06 PM

Post# of 232961
Guys I think I know why CYDY has been trading low.It's been taking forever for FDA approval date keeps getting pushed back. That's fine, the problem is that competition has been getting better in the HIV space.

Look at GlaxoSmithKline with its ViiV healthcare unit it has come up with solid viral load suppression for HIV patients by given them an injection once every 2 months. I know CYDY might appeal more on safety possibly, but while Pro140 will be taken weekly, Glaxo's HIV treatment only needs to be taken 6 times the entire year.

https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-reports-positive-phase-iii-study-results-of-investigational-long-acting-injectable-hiv-treatment-regimen-administered-every-two-months/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News